Nancy Gray, the new director of UAMS BioVentures, has more than 30 years of experience in biomedical industries, including medicinal chemistry research, management of pharmaceutical research and development, and business operations.
Gray comes to UAMS from the Southern Research Institute in Birmingham, Alabama, where she was vice president for corporate development. There, she led corporate development opportunities, including mergers and acquisitions, strategic alliances, joint ventures, minority investments, technology licenses and divestitures for the life sciences, engineering, and environment and energy business. Before coming to the Southern Research Institute, Gray worked in various executive roles at Beijing Med-Pharm Corp., Vaxinnate Corp. and Elan Corp.
Gray’s research work on central nervous system diseases resulted in three products being accepted for clinical development in five years. She was also instrumental in the development of two marketed second-generation antihistamines, Allegra and Xyzal. Gray is the inventor on 31 issued U.S. patents and the author of 23 publications.
Gray received her bachelor’s degree in chemistry from Bucknell University and her doctorate in medicinal chemistry from the University of Illinois.
UAMS BioVentures is the technology licensing office and business incubator for the University of Arkansas for Medical Sciences.